Results 101 to 110 of about 6,798 (212)
Clinical Development of Experimental Therapies for Malignant Glioma
Advances in medical and surgical treatments in the last two to three decades have resulted in quantum leaps in the overall survival of patients with many types of non-central nervous system (CNS) malignant disease, while survival of patients with ...
Nikolai G Rainov, Volkmar Heidecke
doaj
Hematopoietic stem cell transplantation (HSCT) offers curative therapy for patients with hemoglobinopathies, congenital immunodeficiencies, and other conditions, possibly including AIDS.
Scadden, David +12 more
core +1 more source
SUMMARY A ricin A chain immunotoxin, SEN36-ricin A chain, directed against the neural cell adhesion molecule (N-CAM) had no selective cytotoxic activity against three different small cell lung cancer (SCLC) cell lines in tissue culture ...
R A STAHEL +2 more
core +1 more source
11 p.-6 fig.TGF-beta superfamily co-receptors are emerging as targets for cancer therapy, acting both directly on cells and indirectly on the tumour neovasculature.
Córdoba-Díaz, Damián +9 more
core +1 more source
Key Points A phase 1 trial of the anti-CD22 immunotoxin moxetumomab pasudotox was conducted in children with ALL. A 32% objective response rate was observed, including 11 composite complete responses (23%), 5 of which were minimal residual
James A. Whitlock +11 more
core +1 more source
CD64-directed immunotoxin inhibits arthritis in a novel CD64 transgenic rat model
S.5833-5838Macrophages are known to play a key role during inflammation in rheumatoid arthritis (RA). Inflammatory macrophages have increased expression of CD64, the high-affinity receptor for IgG.
Walraven, V. +7 more
core
Citation: 'immunotoxin' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.13326 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms.
openaire +1 more source
Introduction: Antibody-based immunotoxins are a promising novel therapeutic approach aimed at targeted cancer therapy, utilizing the target specificity of antibody fragments attached to a potent cytotoxic ...
Safar Farajnia +4 more
core +1 more source
Amantadine potentiates T lymphocyte killing by an anti-pan-T cell (CD5) ricin A-chain immunotoxin
The studies described in this report demonstrate that 1-adamantanamine hydrochloride (amantadine) is a potent enhancer of the cytotoxic activity of the anti-pan-T lymphocyte (CD5) T101 monoclonal antibody conjugated to purified ricin A-chain (T101 ...
S. Villa +4 more
core +1 more source
Tailoring Immunotoxin AS Anticancer Drug [PDF]
The conventional treatments for cancer have been considered unsatisfatory, with limited efficiency in terms of discriminative cancer cell adverse reaction against the normal compartments, a number of immunological approaches had been implemented.
Asikin, N. (Nur) +6 more
core

